Duane B. Huggett

Toxicity of Select Beta Adrenergic Receptor-Blocking Pharmaceuticals (B-Blockers) on Aquatic Organisms

Duane B. Huggett, Bryan W. Brooks, Bethany N Peterson et al. · Archives of Environmental Contamination and Toxicology · 2001 · 399 citations

Molecular Pharmacology, Endocrine Disruptors, Pharmacological Study +8

Repeating History: Pharmaceuticals in the Environment

Gerald T. Ankley, Bryan W. Brooks, Duane B. Huggett et al. · Environmental Science & Technology · 2007 · 381 citations · Full text

Preclinical Therapeutics, Pharmaceutical Research, Pharmaceutical Innovation +22

A Theoretical Model for Utilizing Mammalian Pharmacology and Safety Data to Prioritize Potential Impacts of Human Pharmaceuticals to Fish

Duane B. Huggett, Jon C. Cook, Jon F. Ericson et al. · Human and Ecological Risk Assessment An International Journal · 2003 · 321 citations

Environmental Species, Pharmacological Study, Human Pharmaceuticals +20

Waterborne and sediment toxicity of fluoxetine to select organisms

Bryan W. Brooks, Philip K. Turner, Jacob K. Stanley et al. · Chemosphere · 2003 · 253 citations

Ecotoxicity, Sediment Toxicity, Environmental Engineering +5

Determination of beta-adrenergic receptor blocking pharmaceuticals in united states wastewater effluent

Duane B. Huggett, Ijaz Khan, Christy M. Foran et al. · Environmental Pollution · 2002 · 200 citations

Pharmaceutical Science, Beta-adrenergic Receptor, Engineering +9